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The cover shows the schematic of liposomal formulations for single drug-loaded nanoparticles of doxorubicin and carfilzomib (top and middle, respectively) and the carfilzomib and doxorubicin dual-loaded combination nanoparticle (bottom). Doxorubicin was chemically conjugated to a phospholipid via a labile hydrazone bond, while carfilzomib was passively loaded into the lipid bilayer. The dual drug-loaded combination nanoparticle demonstrated synergy in vitro and was more efficacious in inhibiting tumor growth in vivo than a combination of free drugs or single-agent liposomes. For more information, see the article by Ashley and colleagues beginning on page 1452. To request permission to re-use all or part of this article, contact the AACR Publications Department at
